ABOUT US
HOME
      Performance Oriented
      Open Communication
      Partnership
      MISSION
      We are dedicated to improving the beauty and health of humanity
      Through innovative R&D work based on value of a socially responsible enterprise
      VISION
      A global leader in the regenerative medicine industry,
      Pioneering improvements in life quality through passionate challenges
      HISTORY
      2023
      • Awarded 30 Million-dollar Export Tower
      • Launch of REJULIFT
      • Opening of PharmaResearch USA Branch Office
      2022
      • REJUVIEL® W, C Launch
      • PharmaResearch R&D Center Completed in the 2nd Pangyo
      • Selected as KOSDAQ Rising Star
      • Selected as The National Top 1000 Innovative Companies
      • PLUTO acquisition
      2021
      • Company name change
      • Selected as KOSDAQ Rising Star
      • REJURAN HB plus® Launch
      • MEDICOSON acquisition
      2020
      • Selected as KOSDAQ Right Star by the Korea Exchange
      • Awarded the ‘Excellent Companies to Work’ at Gangwon-do
      • Class 2 medical device approval and launch of REJUMATE® Injector
      • Expansion and relocation of Pangyo Office (62, Pangyo-ro 255beon-gil)
      2019
      • CONJURAN® listed as New Health Technology (NECA)
      • 2nd Gangneung GMP factory completed
      • Extension of certification as an Innovative Pharmaceutical Company (MOHW)
      2018
      • Acquisition of CLEVIEL business unit from Aestura
      • Est. PharmaResearch BIO, a bio-venture company specializing in biological products
      2017
      • REJURAN CE certified
      • REJURAN Healer Cosmetics launched
      • Awarded the Industrial Award for Conservation of Fisheries Resources
      • Awarded 10 Million-dollar Export Tower
      • Started construction of 2nd Gangneung GMP factory
      • Signed a binding MOU for acquisition of BIOCND
      2016
      • Joint research agreement of functional peptide
      • Certified as an Innovative Pharmaceutical Company
      • Acquisition of DR.J Organic Cosmetics
      • D+CELL Cosmetics lineup expansion
      • REJURAN i, REJURAN s launched
      • Acquired patent for thermosensitive hydrogel
      2015
      • Released Rejuvenex injection, Re-An eye drops
      • Listed on KOSDAQ
      2014
      • Registered PDRN DMF
      • Released Rejuran
      • Opend Anti-Aging Regenerative Medicine Research Center(Pangyo)
      2013
      • Completed construction of GMP plant in Gangneung and approval obtained for manufacturing business
      2008
      • Approval obtained for Placentex injection, a tissue regenerative medicine
      • Study of PDRN's Localization(cooperation width KIST)
      2007
      • Executed cxclusive sales contract with Mastelli of Italy
      • Released ATP injection, a metabolism activation drug
      2004
      • Released JBP
      2002
      • Introduced BTXA (Botox of China) to Korean market
      2000
      • Relesed Zadaxin, an anti-cancer immune modulating drug
      1994
      • Executed contract with Omron of Japan
      • Launched product license and authorization developement consulting service (approximately 700 products licensed and authorized)
      1993
      • Korea's first pharmaceutical consulting firm
      CI

      The symbol mark of PharmaResearch visualizes the core values of PharmaResearch, a biopharmaceutical company specializing in regenerative medicine.
      The oval-shaped symbol, derived from the English wordmark of PharmaResearch, embodies the relentless spirit of continuous research and innovation.
      Plus icon in upper right, combined of these values and the core color of green, represents significant trust in bio-pharmaceuticals
      that embody robust vitality through the application of regenerative medicine technology, as well as clean and safe raw materials.

      Signature

      Symbol Mark

      Top-bottom pattern in Korean

      Left-right pattern in English

      COLOR SYSTEM

      Pantone 361C

      Green

      White

      CI Download

      AFFILIATE
      PharmaResearch Co. Ltd
      Location Gangneung, Gangwon State
      Main Business Development and manufacturing of Botulinum Toxin
      MEDICOSON
      Location Wonju, Gangwon State
      Main Business Development, manufacturing, and sales of high-frequency stimulator and cosmetic device
      DR.J SKIN CLINIC
      Location DR.J SKIN CLINIC
      Main Business Development, manufacturing, and sales of hospital cosmetics and organic cosmetics
      PLUTO
      Location Seongnam, Gyeonggi-do
      Main Business Pharmaceutical development and consulting
      SOO INVESTMENT CAPITAL
      Location Seongnam, Gyeonggi-do
      Main Business Venture Investment
      CONTACT
      • 77-19, Gwahakdanji-ro, Gangneung-si, Gangwon State, Korea, Postal Code 25452
      • +82-33-645-7640
      • +82-33-645-7642
      • 62, Pangyo-ro 255, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea, Postal Code 13486
      • +82-31-8039-1500
      • +82-31-8039-1501~2
      • 22, Geumto-ro 40, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea, Postal Code 13543
      • +82-31-8039-1500
      • +82-31-8039-1501~2